Pharmacy Law

Pharmacy Law Related Articles

Exploring Pharmaceutical Manufacturer and Specialty Pharmacy Relationships: What You Can and Cannot Do

The Impact of DIR Fees on 340B Relationships Between Contract Pharmacies and Covered Entities

White Paper: "Performance" Based DIR Fees: A Rigged System with Disparate Effect on Specialty Pharmacies, Medicare Part D Beneficiaries and the U.S. Healthcare System

The 21st Century Cures Act: Its Impact on Home Infusion and How Providers Can Respond

Two States Enact PBM Licensure Requirements

PHARMACY ALERT: Roche Begins Issuing Demand Letters Seeking Repayment for Test Strips Claims

HHS withdraws 340B Mega Guidance

White Paper: PBM DIR Fees Costing Medicare and Beneficiaries: Investigative White Paper on Background, Cost Impact, and Legal Issues

New Auditing Trend Highlights Need to Verify Exclusion Status of Prescribers

Opioid Prescribing and the Importance of Knowing Naloxone Dispensing Laws

Exploring Pharmaceutical Manufacturer and Specialty Pharmacy Relationships: What You Can and Cannot Do

 

 

In an industry where supply chains are closely monitored, patient data is king, and complex medications require high-touch services by distribution partners, biologics and pharmaceutical manufacturers have turned to specialty pharmacies to assist. However, these arrangements are closely scrutinized and must be structured to ensure compliance with state and federal laws.

In this webinar, attorneys Jesse C. Dresser, Esq., and John E. Morrone, Esq., provide an overview of the types of arrangements between manufacturers and specialty pharmacies and the legal and business considerations of those relationships. We will also examine the regulatory and payer risks and considerations.

From this presentation, attendees will:

 If you have any questions or concerns regarding arrangements, or other issues with your specialty pharmacy, contact Frier Levitt today to speak to an attorney. Frier Levitt helps specialty pharmacies and life science companies on a routine basis deal with many issues including PBM audits and network access, as well as regulatory and transactional advice.

This webinar is presented through a partnership with Mediware.

 

Subscribe

 

Copyright © 2017, Frier Levitt, LLC. All rights reserved. All content of this blog is the property and copyright of Frier Levitt, LLC and may not be reproduced in any format without prior express permission. Contact us for more information or to seek permission to reproduce content. This blog is intended for general information purposes only. It does not constitute legal advice. The reader should consult with knowledgeable legal counsel to determine how applicable laws apply to specific facts and situations. Blog posts are based on the most current information at the time they are written. Since it is possible that the laws or other circumstances may have changed since publication, please contact us to discuss any action you may be considering as a result of reading this blog.